# Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis

> **NCT05808010** · NA · UNKNOWN · sponsor: **Shandong Provincial Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Atrophic Gastritis

## Interventions

- **BIOLOGICAL:** Mononuclear cells
- **DRUG:** Weifuchun+Hydrotalcite/L-Glutamine and Sodium Gualenate Granules

## Key facts

- **NCT ID:** NCT05808010
- **Lead sponsor:** Shandong Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-07
- **Primary completion:** 2025-04
- **Final completion:** 2026-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05808010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05808010, "Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05808010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*